Rigel Pharmaceuticals, Inc. (RIGL) Revenue History
Rigel Pharmaceuticals, Inc. (RIGL) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $20.38M |
| 2017-12-31 | $4.48M |
| 2018-12-31 | $44.51M |
| 2019-12-31 | $59.29M |
| 2020-12-31 | $108.62M |
| 2021-12-31 | $149.24M |
| 2022-12-31 | $120.24M |
| 2023-12-31 | $116.88M |
| 2024-12-31 | $179.28M |
| 2025-12-31 | $294.28M |
How RIGL compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| FLGT | Fulgent Genetics Inc. | $322.67M |
| EOLS | Evolus Inc. | $297.18M |
| VCEL | Vericel Corporation | $276.26M |
| HROW | Harrow Inc Com | $272.30M |
| IOVA | Iovance Biotherapeutics Inc. | $263.50M |
These are five companies in the same sector as RIGL with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Rigel Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("RIGL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RIGL | $45.89 | +1.41% | 0.32M |
| 3 | ||||
| 4 | ||||
| 5 |